Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg

$ 25.00 · 4.6 (316) · In stock

The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.

Metro makes formal $4.5B cash and stock offer for Jean Coutu - BNN Bloomberg

How Not to Negotiate a $6.1 Billion Deal - Bloomberg

US wholesale prices picked up in February in sign that inflation pressures remain elevated, SiouxlandProud, Sioux City, IA

Home Depot Sales Drop for Fifth Straight Quarter on Weak Demand - BNN Bloomberg

Jean Coutu Q1 revenue up, profit down on Pro Doc brand - BNN Bloomberg

How Not to Negotiate a $6.1 Billion Deal - Bloomberg

Jean Coutu profits up despite generics

Where Bits and Bytes Meet Brick-and-Mortar Retail

BNN's Daily Chase: NHL playoffs boost Canada's economy; Clark's government toppled in B.C. - BNN Bloomberg

QSR) Burger King Owner's Fourth-Quarter Sales Outpace Expectations - Bloomberg

Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer - BNN Bloomberg

Mulling Over Margin, Part 1: Introduction and Historical Background - farmdoc daily

Grocers brace for generic drug deal; Loblaw stock downgraded by Desjardins - BNN Bloomberg